nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—DDC—telencephalic ventricle—Alzheimer's disease	0.048	0.259	CbGeAlD
Methyldopa—COMT—telencephalic ventricle—Alzheimer's disease	0.0318	0.171	CbGeAlD
Methyldopa—DDC—embryo—Alzheimer's disease	0.0142	0.0764	CbGeAlD
Methyldopa—DDC—forebrain—Alzheimer's disease	0.0125	0.0676	CbGeAlD
Methyldopa—Parkinsonism—Memantine—Alzheimer's disease	0.0119	0.0253	CcSEcCtD
Methyldopa—Parkinsonism—Rivastigmine—Alzheimer's disease	0.0116	0.0247	CcSEcCtD
Methyldopa—DDC—telencephalon—Alzheimer's disease	0.0115	0.0622	CbGeAlD
Methyldopa—COMT—forebrain—Alzheimer's disease	0.0083	0.0447	CbGeAlD
Methyldopa—COMT—telencephalon—Alzheimer's disease	0.00763	0.0411	CbGeAlD
Methyldopa—Nightmare—Galantamine—Alzheimer's disease	0.00739	0.0158	CcSEcCtD
Methyldopa—DDC—nervous system—Alzheimer's disease	0.00681	0.0367	CbGeAlD
Methyldopa—DDC—central nervous system—Alzheimer's disease	0.00656	0.0353	CbGeAlD
Methyldopa—Endocrine disorder—Memantine—Alzheimer's disease	0.0065	0.0138	CcSEcCtD
Methyldopa—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00551	0.0117	CcSEcCtD
Methyldopa—Vasculitis—Rivastigmine—Alzheimer's disease	0.0054	0.0115	CcSEcCtD
Methyldopa—DDC—brain—Alzheimer's disease	0.00521	0.028	CbGeAlD
Methyldopa—Nightmare—Memantine—Alzheimer's disease	0.0052	0.0111	CcSEcCtD
Methyldopa—Colitis—Memantine—Alzheimer's disease	0.00517	0.011	CcSEcCtD
Methyldopa—Nightmare—Rivastigmine—Alzheimer's disease	0.00509	0.0108	CcSEcCtD
Methyldopa—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00507	0.0108	CcSEcCtD
Methyldopa—Colitis—Rivastigmine—Alzheimer's disease	0.00506	0.0108	CcSEcCtD
Methyldopa—Eczema—Donepezil—Alzheimer's disease	0.00479	0.0102	CcSEcCtD
Methyldopa—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00477	0.0102	CcSEcCtD
Methyldopa—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.00475	0.0101	CcSEcCtD
Methyldopa—Libido decreased—Donepezil—Alzheimer's disease	0.00464	0.0099	CcSEcCtD
Methyldopa—COMT—nervous system—Alzheimer's disease	0.0045	0.0243	CbGeAlD
Methyldopa—Eczema—Memantine—Alzheimer's disease	0.00435	0.00927	CcSEcCtD
Methyldopa—COMT—central nervous system—Alzheimer's disease	0.00434	0.0234	CbGeAlD
Methyldopa—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00431	0.00919	CcSEcCtD
Methyldopa—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.00427	0.0091	CcSEcCtD
Methyldopa—Eczema—Rivastigmine—Alzheimer's disease	0.00426	0.00907	CcSEcCtD
Methyldopa—COMT—cerebellum—Alzheimer's disease	0.00424	0.0228	CbGeAlD
Methyldopa—ADRA2A—forebrain—Alzheimer's disease	0.00422	0.0228	CbGeAlD
Methyldopa—Libido decreased—Memantine—Alzheimer's disease	0.00422	0.00898	CcSEcCtD
Methyldopa—Psychotic disorder—Donepezil—Alzheimer's disease	0.00421	0.00896	CcSEcCtD
Methyldopa—Libido decreased—Rivastigmine—Alzheimer's disease	0.00412	0.00879	CcSEcCtD
Methyldopa—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00405	0.00863	CcSEcCtD
Methyldopa—Liver function test abnormal—Donepezil—Alzheimer's disease	0.00398	0.00847	CcSEcCtD
Methyldopa—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00393	0.00838	CcSEcCtD
Methyldopa—Bradycardia—Galantamine—Alzheimer's disease	0.00391	0.00834	CcSEcCtD
Methyldopa—ADRA2A—telencephalon—Alzheimer's disease	0.00388	0.0209	CbGeAlD
Methyldopa—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00388	0.00827	CcSEcCtD
Methyldopa—Hepatitis—Galantamine—Alzheimer's disease	0.00384	0.00819	CcSEcCtD
Methyldopa—Psychotic disorder—Memantine—Alzheimer's disease	0.00382	0.00814	CcSEcCtD
Methyldopa—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00379	0.00809	CcSEcCtD
Methyldopa—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00378	0.00805	CcSEcCtD
Methyldopa—Abdominal distension—Donepezil—Alzheimer's disease	0.00375	0.00798	CcSEcCtD
Methyldopa—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00374	0.00796	CcSEcCtD
Methyldopa—Eosinophilia—Donepezil—Alzheimer's disease	0.00368	0.00785	CcSEcCtD
Methyldopa—Pancreatitis—Donepezil—Alzheimer's disease	0.00365	0.00778	CcSEcCtD
Methyldopa—Angina pectoris—Donepezil—Alzheimer's disease	0.00363	0.00773	CcSEcCtD
Methyldopa—Liver function test abnormal—Memantine—Alzheimer's disease	0.00361	0.00769	CcSEcCtD
Methyldopa—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00357	0.00761	CcSEcCtD
Methyldopa—Cardiac disorder—Galantamine—Alzheimer's disease	0.00357	0.0076	CcSEcCtD
Methyldopa—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.00353	0.00753	CcSEcCtD
Methyldopa—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00349	0.00744	CcSEcCtD
Methyldopa—Angiopathy—Galantamine—Alzheimer's disease	0.00349	0.00743	CcSEcCtD
Methyldopa—Breast disorder—Rivastigmine—Alzheimer's disease	0.00346	0.00737	CcSEcCtD
Methyldopa—COMT—brain—Alzheimer's disease	0.00344	0.0185	CbGeAlD
Methyldopa—Weight increased—Donepezil—Alzheimer's disease	0.00339	0.00722	CcSEcCtD
Methyldopa—Mental disorder—Galantamine—Alzheimer's disease	0.00337	0.00718	CcSEcCtD
Methyldopa—Infestation—Donepezil—Alzheimer's disease	0.00332	0.00707	CcSEcCtD
Methyldopa—Infestation NOS—Donepezil—Alzheimer's disease	0.00332	0.00707	CcSEcCtD
Methyldopa—Pancreatitis—Memantine—Alzheimer's disease	0.00331	0.00706	CcSEcCtD
Methyldopa—Flatulence—Galantamine—Alzheimer's disease	0.0033	0.00703	CcSEcCtD
Methyldopa—Angina pectoris—Memantine—Alzheimer's disease	0.00329	0.00701	CcSEcCtD
Methyldopa—Pancreatitis—Rivastigmine—Alzheimer's disease	0.00324	0.00691	CcSEcCtD
Methyldopa—Jaundice—Donepezil—Alzheimer's disease	0.00323	0.00689	CcSEcCtD
Methyldopa—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00322	0.00686	CcSEcCtD
Methyldopa—Pancytopenia—Memantine—Alzheimer's disease	0.00321	0.00684	CcSEcCtD
Methyldopa—Erectile dysfunction—Memantine—Alzheimer's disease	0.00311	0.00663	CcSEcCtD
Methyldopa—Weight increased—Memantine—Alzheimer's disease	0.00308	0.00655	CcSEcCtD
Methyldopa—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00304	0.00649	CcSEcCtD
Methyldopa—Bradycardia—Donepezil—Alzheimer's disease	0.00303	0.00646	CcSEcCtD
Methyldopa—Infestation NOS—Memantine—Alzheimer's disease	0.00301	0.00642	CcSEcCtD
Methyldopa—Infestation—Memantine—Alzheimer's disease	0.00301	0.00642	CcSEcCtD
Methyldopa—Weight increased—Rivastigmine—Alzheimer's disease	0.00301	0.00641	CcSEcCtD
Methyldopa—Hepatitis—Donepezil—Alzheimer's disease	0.00298	0.00635	CcSEcCtD
Methyldopa—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00295	0.00628	CcSEcCtD
Methyldopa—Infestation—Rivastigmine—Alzheimer's disease	0.00295	0.00628	CcSEcCtD
Methyldopa—Aminosalicylic Acid—MPO—Alzheimer's disease	0.00295	0.165	CrCbGaD
Methyldopa—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00285	0.00607	CcSEcCtD
Methyldopa—Arthralgia—Galantamine—Alzheimer's disease	0.00285	0.00607	CcSEcCtD
Methyldopa—Myalgia—Galantamine—Alzheimer's disease	0.00285	0.00607	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00283	0.00603	CcSEcCtD
Methyldopa—Agranulocytosis—Memantine—Alzheimer's disease	0.00281	0.00599	CcSEcCtD
Methyldopa—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00279	0.00594	CcSEcCtD
Methyldopa—Bradycardia—Memantine—Alzheimer's disease	0.00275	0.00587	CcSEcCtD
Methyldopa—Hepatitis—Memantine—Alzheimer's disease	0.0027	0.00576	CcSEcCtD
Methyldopa—Bradycardia—Rivastigmine—Alzheimer's disease	0.00269	0.00574	CcSEcCtD
Methyldopa—Nervous system disorder—Galantamine—Alzheimer's disease	0.00268	0.00571	CcSEcCtD
Methyldopa—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00267	0.0057	CcSEcCtD
Methyldopa—Connective tissue disorder—Memantine—Alzheimer's disease	0.00266	0.00566	CcSEcCtD
Methyldopa—Skin disorder—Galantamine—Alzheimer's disease	0.00265	0.00565	CcSEcCtD
Methyldopa—Hepatitis—Rivastigmine—Alzheimer's disease	0.00265	0.00564	CcSEcCtD
Methyldopa—Mental disorder—Donepezil—Alzheimer's disease	0.00261	0.00556	CcSEcCtD
Methyldopa—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.0026	0.00554	CcSEcCtD
Methyldopa—Flatulence—Donepezil—Alzheimer's disease	0.00256	0.00545	CcSEcCtD
Methyldopa—Cardiac disorder—Memantine—Alzheimer's disease	0.00251	0.00535	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00249	0.0053	CcSEcCtD
Methyldopa—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00246	0.00523	CcSEcCtD
Methyldopa—Angiopathy—Memantine—Alzheimer's disease	0.00245	0.00523	CcSEcCtD
Methyldopa—Paraesthesia—Galantamine—Alzheimer's disease	0.00245	0.00523	CcSEcCtD
Methyldopa—Mediastinal disorder—Memantine—Alzheimer's disease	0.00244	0.00519	CcSEcCtD
Methyldopa—Angiopathy—Rivastigmine—Alzheimer's disease	0.0024	0.00512	CcSEcCtD
Methyldopa—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00238	0.00508	CcSEcCtD
Methyldopa—Mental disorder—Memantine—Alzheimer's disease	0.00237	0.00505	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00236	0.00502	CcSEcCtD
Methyldopa—Constipation—Galantamine—Alzheimer's disease	0.00234	0.00498	CcSEcCtD
Methyldopa—Flatulence—Memantine—Alzheimer's disease	0.00232	0.00494	CcSEcCtD
Methyldopa—Mental disorder—Rivastigmine—Alzheimer's disease	0.00232	0.00494	CcSEcCtD
Methyldopa—Mesalazine—MPO—Alzheimer's disease	0.00231	0.13	CrCbGaD
Methyldopa—ADRA2A—nervous system—Alzheimer's disease	0.00229	0.0124	CbGeAlD
Methyldopa—Flatulence—Rivastigmine—Alzheimer's disease	0.00227	0.00484	CcSEcCtD
Methyldopa—ADRA2A—central nervous system—Alzheimer's disease	0.00221	0.0119	CbGeAlD
Methyldopa—Arthralgia—Donepezil—Alzheimer's disease	0.00221	0.0047	CcSEcCtD
Methyldopa—Myalgia—Donepezil—Alzheimer's disease	0.00221	0.0047	CcSEcCtD
Methyldopa—Body temperature increased—Galantamine—Alzheimer's disease	0.00216	0.0046	CcSEcCtD
Methyldopa—ADRA2A—cerebellum—Alzheimer's disease	0.00216	0.0116	CbGeAlD
Methyldopa—Oedema—Donepezil—Alzheimer's disease	0.00212	0.00451	CcSEcCtD
Methyldopa—Leukopenia—Memantine—Alzheimer's disease	0.00211	0.00449	CcSEcCtD
Methyldopa—Infection—Donepezil—Alzheimer's disease	0.0021	0.00448	CcSEcCtD
Methyldopa—Nervous system disorder—Donepezil—Alzheimer's disease	0.00208	0.00442	CcSEcCtD
Methyldopa—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00207	0.00442	CcSEcCtD
Methyldopa—Mesalazine—PPARG—Alzheimer's disease	0.00205	0.115	CrCbGaD
Methyldopa—Hypersensitivity—Galantamine—Alzheimer's disease	0.00201	0.00429	CcSEcCtD
Methyldopa—Arthralgia—Memantine—Alzheimer's disease	0.002	0.00427	CcSEcCtD
Methyldopa—Myalgia—Memantine—Alzheimer's disease	0.002	0.00427	CcSEcCtD
Methyldopa—Myalgia—Rivastigmine—Alzheimer's disease	0.00196	0.00418	CcSEcCtD
Methyldopa—Arthralgia—Rivastigmine—Alzheimer's disease	0.00196	0.00418	CcSEcCtD
Methyldopa—Asthenia—Galantamine—Alzheimer's disease	0.00196	0.00418	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00195	0.00415	CcSEcCtD
Methyldopa—Aminosalicylic Acid—PTGS1—Alzheimer's disease	0.00193	0.108	CrCbGaD
Methyldopa—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00193	0.00411	CcSEcCtD
Methyldopa—Oedema—Memantine—Alzheimer's disease	0.00192	0.0041	CcSEcCtD
Methyldopa—Dopamine—MAOB—Alzheimer's disease	0.00192	0.107	CrCbGaD
Methyldopa—Infection—Memantine—Alzheimer's disease	0.00191	0.00407	CcSEcCtD
Methyldopa—Paraesthesia—Donepezil—Alzheimer's disease	0.0019	0.00405	CcSEcCtD
Methyldopa—Nervous system disorder—Memantine—Alzheimer's disease	0.00188	0.00402	CcSEcCtD
Methyldopa—Thrombocytopenia—Memantine—Alzheimer's disease	0.00188	0.00401	CcSEcCtD
Methyldopa—Oedema—Rivastigmine—Alzheimer's disease	0.00188	0.00401	CcSEcCtD
Methyldopa—Diarrhoea—Galantamine—Alzheimer's disease	0.00187	0.00398	CcSEcCtD
Methyldopa—Infection—Rivastigmine—Alzheimer's disease	0.00187	0.00398	CcSEcCtD
Methyldopa—Skin disorder—Memantine—Alzheimer's disease	0.00187	0.00398	CcSEcCtD
Methyldopa—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00184	0.00393	CcSEcCtD
Methyldopa—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00184	0.00392	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00183	0.00389	CcSEcCtD
Methyldopa—Skin disorder—Rivastigmine—Alzheimer's disease	0.00183	0.00389	CcSEcCtD
Methyldopa—Constipation—Donepezil—Alzheimer's disease	0.00181	0.00386	CcSEcCtD
Methyldopa—Dizziness—Galantamine—Alzheimer's disease	0.00181	0.00385	CcSEcCtD
Methyldopa—ADRA2A—brain—Alzheimer's disease	0.00175	0.00945	CbGeAlD
Methyldopa—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00175	0.00373	CcSEcCtD
Methyldopa—Vomiting—Galantamine—Alzheimer's disease	0.00174	0.0037	CcSEcCtD
Methyldopa—Paraesthesia—Memantine—Alzheimer's disease	0.00173	0.00368	CcSEcCtD
Methyldopa—Rash—Galantamine—Alzheimer's disease	0.00172	0.00367	CcSEcCtD
Methyldopa—Dermatitis—Galantamine—Alzheimer's disease	0.00172	0.00367	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00171	0.00365	CcSEcCtD
Methyldopa—Headache—Galantamine—Alzheimer's disease	0.00171	0.00365	CcSEcCtD
Methyldopa—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00169	0.0036	CcSEcCtD
Methyldopa—Body temperature increased—Donepezil—Alzheimer's disease	0.00167	0.00357	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00166	0.00354	CcSEcCtD
Methyldopa—Constipation—Memantine—Alzheimer's disease	0.00164	0.0035	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00162	0.00346	CcSEcCtD
Methyldopa—Nausea—Galantamine—Alzheimer's disease	0.00162	0.00346	CcSEcCtD
Methyldopa—Constipation—Rivastigmine—Alzheimer's disease	0.00161	0.00343	CcSEcCtD
Methyldopa—Hypersensitivity—Donepezil—Alzheimer's disease	0.00156	0.00332	CcSEcCtD
Methyldopa—Body temperature increased—Memantine—Alzheimer's disease	0.00152	0.00324	CcSEcCtD
Methyldopa—Asthenia—Donepezil—Alzheimer's disease	0.00152	0.00324	CcSEcCtD
Methyldopa—Mesalazine—PTGS1—Alzheimer's disease	0.00152	0.085	CrCbGaD
Methyldopa—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00149	0.00317	CcSEcCtD
Methyldopa—Diarrhoea—Donepezil—Alzheimer's disease	0.00145	0.00309	CcSEcCtD
Methyldopa—Hypersensitivity—Memantine—Alzheimer's disease	0.00142	0.00302	CcSEcCtD
Methyldopa—Dizziness—Donepezil—Alzheimer's disease	0.0014	0.00298	CcSEcCtD
Methyldopa—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00139	0.00295	CcSEcCtD
Methyldopa—Asthenia—Memantine—Alzheimer's disease	0.00138	0.00294	CcSEcCtD
Methyldopa—Asthenia—Rivastigmine—Alzheimer's disease	0.00135	0.00287	CcSEcCtD
Methyldopa—Vomiting—Donepezil—Alzheimer's disease	0.00135	0.00287	CcSEcCtD
Methyldopa—Rash—Donepezil—Alzheimer's disease	0.00133	0.00284	CcSEcCtD
Methyldopa—Dermatitis—Donepezil—Alzheimer's disease	0.00133	0.00284	CcSEcCtD
Methyldopa—Headache—Donepezil—Alzheimer's disease	0.00133	0.00283	CcSEcCtD
Methyldopa—Diarrhoea—Memantine—Alzheimer's disease	0.00131	0.0028	CcSEcCtD
Methyldopa—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00129	0.00274	CcSEcCtD
Methyldopa—Dizziness—Memantine—Alzheimer's disease	0.00127	0.00271	CcSEcCtD
Methyldopa—Nausea—Donepezil—Alzheimer's disease	0.00126	0.00268	CcSEcCtD
Methyldopa—Dizziness—Rivastigmine—Alzheimer's disease	0.00124	0.00265	CcSEcCtD
Methyldopa—Vomiting—Memantine—Alzheimer's disease	0.00122	0.0026	CcSEcCtD
Methyldopa—Rash—Memantine—Alzheimer's disease	0.00121	0.00258	CcSEcCtD
Methyldopa—Dermatitis—Memantine—Alzheimer's disease	0.00121	0.00258	CcSEcCtD
Methyldopa—Headache—Memantine—Alzheimer's disease	0.0012	0.00257	CcSEcCtD
Methyldopa—Vomiting—Rivastigmine—Alzheimer's disease	0.0012	0.00255	CcSEcCtD
Methyldopa—Rash—Rivastigmine—Alzheimer's disease	0.00119	0.00253	CcSEcCtD
Methyldopa—Dermatitis—Rivastigmine—Alzheimer's disease	0.00118	0.00252	CcSEcCtD
Methyldopa—Headache—Rivastigmine—Alzheimer's disease	0.00118	0.00251	CcSEcCtD
Methyldopa—Nausea—Memantine—Alzheimer's disease	0.00114	0.00243	CcSEcCtD
Methyldopa—Nausea—Rivastigmine—Alzheimer's disease	0.00112	0.00238	CcSEcCtD
Methyldopa—Aminosalicylic Acid—PTGS2—Alzheimer's disease	0.0011	0.0619	CrCbGaD
Methyldopa—Epinephrine—TNF—Alzheimer's disease	0.00105	0.0589	CrCbGaD
Methyldopa—Mesalazine—PTGS2—Alzheimer's disease	0.000867	0.0486	CrCbGaD
Methyldopa—Dopamine—SLC6A4—Alzheimer's disease	0.000866	0.0486	CrCbGaD
Methyldopa—L-DOPA—CYP2D6—Alzheimer's disease	0.000655	0.0367	CrCbGaD
Methyldopa—Dopamine—CYP2D6—Alzheimer's disease	0.000609	0.0342	CrCbGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000405	0.00124	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ND1—Alzheimer's disease	0.000402	0.00123	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000401	0.00123	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—INS—Alzheimer's disease	0.000398	0.00122	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000377	0.00115	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—TF—Alzheimer's disease	0.000374	0.00114	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—NPY—Alzheimer's disease	0.000373	0.00114	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—CREB1—Alzheimer's disease	0.000359	0.0011	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—MAPK8—Alzheimer's disease	0.000358	0.00109	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000347	0.00106	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR6—Alzheimer's disease	0.000346	0.00106	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—GAB2—Alzheimer's disease	0.000342	0.00104	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000341	0.00104	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—APP—Alzheimer's disease	0.000333	0.00102	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—SST—Alzheimer's disease	0.000325	0.000994	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CDK5—Alzheimer's disease	0.000321	0.000982	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—APP—Alzheimer's disease	0.000317	0.000969	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—INS—Alzheimer's disease	0.000313	0.000956	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000296	0.000906	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TPI1—Alzheimer's disease	0.000292	0.000892	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CHAT—Alzheimer's disease	0.000292	0.000892	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—Alzheimer's disease	0.000288	0.000881	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GAL—Alzheimer's disease	0.000287	0.000878	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.00028	0.000855	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MAOB—Alzheimer's disease	0.00028	0.000855	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—SOD1—Alzheimer's disease	0.000271	0.000829	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000271	0.000828	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GAPDH—Alzheimer's disease	0.000269	0.000823	CbGpPWpGaD
Methyldopa—DDC—Metabolism—A2M—Alzheimer's disease	0.00026	0.000795	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CHAT—Alzheimer's disease	0.000259	0.000792	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TPI1—Alzheimer's disease	0.000259	0.000792	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000259	0.00079	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF2—Alzheimer's disease	0.000258	0.000788	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CLU—Alzheimer's disease	0.000254	0.000776	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000252	0.00077	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—TP53—Alzheimer's disease	0.00025	0.000763	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MAOB—Alzheimer's disease	0.000249	0.000759	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DHCR24—Alzheimer's disease	0.000248	0.000758	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GAPDH—Alzheimer's disease	0.000239	0.000731	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000238	0.000729	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PYY—Alzheimer's disease	0.000234	0.000716	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—PRKCG—Alzheimer's disease	0.000232	0.00071	CbGpPWpGaD
Methyldopa—COMT—Metabolism—A2M—Alzheimer's disease	0.000231	0.000706	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—IL6—Alzheimer's disease	0.000229	0.000698	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—A2M—Alzheimer's disease	0.000226	0.000692	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ACHE—Alzheimer's disease	0.000226	0.000692	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—NPY—Alzheimer's disease	0.000226	0.00069	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—IAPP—Alzheimer's disease	0.000224	0.000685	CbGpPWpGaD
Methyldopa—DDC—Metabolism—INPP5D—Alzheimer's disease	0.000224	0.000684	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CRH—Alzheimer's disease	0.000218	0.000665	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PYY—Alzheimer's disease	0.000213	0.00065	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ENO1—Alzheimer's disease	0.000212	0.000648	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS1—Alzheimer's disease	0.000212	0.000648	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CA4—Alzheimer's disease	0.000211	0.000645	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CCR5—Alzheimer's disease	0.00021	0.00064	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP2D6—Alzheimer's disease	0.000208	0.000636	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—NPS—Alzheimer's disease	0.000206	0.000631	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	0.000201	0.000614	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ACHE—Alzheimer's disease	0.000201	0.000614	CbGpPWpGaD
Methyldopa—COMT—Metabolism—INPP5D—Alzheimer's disease	0.000199	0.000607	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GAPDHS—Alzheimer's disease	0.000198	0.000606	CbGpPWpGaD
Methyldopa—DDC—Metabolism—BCHE—Alzheimer's disease	0.000197	0.000603	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—SST—Alzheimer's disease	0.000197	0.000602	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000196	0.000597	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—INPP5D—Alzheimer's disease	0.000195	0.000595	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000195	0.000594	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TF—Alzheimer's disease	0.000193	0.000588	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—APP—Alzheimer's disease	0.000192	0.000586	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.00019	0.000582	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	0.000189	0.000577	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS1—Alzheimer's disease	0.000188	0.000575	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ENO1—Alzheimer's disease	0.000188	0.000575	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ATP5A1—Alzheimer's disease	0.000188	0.000574	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PLCB1—Alzheimer's disease	0.000186	0.000569	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP2D6—Alzheimer's disease	0.000185	0.000564	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CDK5—Alzheimer's disease	0.000184	0.000564	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ABCA1—Alzheimer's disease	0.00018	0.000551	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLD3—Alzheimer's disease	0.000179	0.000548	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR6—Alzheimer's disease	0.000178	0.000543	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—GAB2—Alzheimer's disease	0.000176	0.000538	CbGpPWpGaD
Methyldopa—COMT—Metabolism—BCHE—Alzheimer's disease	0.000175	0.000535	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HSD17B10—Alzheimer's disease	0.000172	0.000525	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—APP—Alzheimer's disease	0.000172	0.000524	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000167	0.000509	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP46A1—Alzheimer's disease	0.000166	0.000506	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	0.000166	0.000506	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PLCB1—Alzheimer's disease	0.000165	0.000505	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000163	0.000498	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GAL—Alzheimer's disease	0.000162	0.000496	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ABCA1—Alzheimer's disease	0.00016	0.000489	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ND1—Alzheimer's disease	0.00016	0.000488	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPARGC1A—Alzheimer's disease	0.000155	0.000475	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HMOX1—Alzheimer's disease	0.000155	0.000473	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GAL—Alzheimer's disease	0.000147	0.000451	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TTR—Alzheimer's disease	0.000144	0.000439	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000143	0.000437	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LPL—Alzheimer's disease	0.000142	0.000432	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SOD1—Alzheimer's disease	0.00014	0.000427	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPARGC1A—Alzheimer's disease	0.000138	0.000422	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HMOX1—Alzheimer's disease	0.000137	0.00042	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF2—Alzheimer's disease	0.000133	0.000406	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPY—Alzheimer's disease	0.000128	0.00039	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000127	0.000389	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MTHFR—Alzheimer's disease	0.000127	0.000389	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCR5—Alzheimer's disease	0.000127	0.000388	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000127	0.000387	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PYY—Alzheimer's disease	0.000126	0.000384	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LPL—Alzheimer's disease	0.000126	0.000384	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000124	0.000379	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CRH—Alzheimer's disease	0.000123	0.000376	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PRKCG—Alzheimer's disease	0.00012	0.000366	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CALM1—Alzheimer's disease	0.000119	0.000364	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOE—Alzheimer's disease	0.000119	0.000362	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CAV1—Alzheimer's disease	0.000118	0.000359	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPS—Alzheimer's disease	0.000117	0.000356	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPY—Alzheimer's disease	0.000116	0.000354	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IAPP—Alzheimer's disease	0.000115	0.000352	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MTHFR—Alzheimer's disease	0.000113	0.000346	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CRH—Alzheimer's disease	0.000112	0.000341	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000111	0.00034	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—SST—Alzheimer's disease	0.000111	0.00034	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CDK5—Alzheimer's disease	0.000109	0.000333	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—F2—Alzheimer's disease	0.000109	0.000333	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—APP—Alzheimer's disease	0.000108	0.000331	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	0.000108	0.00033	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPS—Alzheimer's disease	0.000106	0.000324	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CALM1—Alzheimer's disease	0.000106	0.000323	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000105	0.000322	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOE—Alzheimer's disease	0.000105	0.000322	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR6—Alzheimer's disease	0.000105	0.00032	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLAU—Alzheimer's disease	0.000105	0.00032	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CAV1—Alzheimer's disease	0.000104	0.000319	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CALM1—Alzheimer's disease	0.000104	0.000317	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPARG—Alzheimer's disease	0.000103	0.000316	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TPI1—Alzheimer's disease	0.000103	0.000315	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CHAT—Alzheimer's disease	0.000103	0.000315	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000102	0.000313	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CAV1—Alzheimer's disease	0.000102	0.000313	CbGpPWpGaD
Methyldopa—DDC—Metabolism—INS—Alzheimer's disease	0.000101	0.00031	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000101	0.000309	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—SST—Alzheimer's disease	0.000101	0.000309	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	9.92e-05	0.000303	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MAOB—Alzheimer's disease	9.88e-05	0.000302	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—APP—Alzheimer's disease	9.85e-05	0.000301	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—F2—Alzheimer's disease	9.74e-05	0.000297	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL2—Alzheimer's disease	9.71e-05	0.000297	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS2—Alzheimer's disease	9.62e-05	0.000294	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PSENEN—Alzheimer's disease	9.53e-05	0.000291	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GAPDH—Alzheimer's disease	9.51e-05	0.00029	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APH1A—Alzheimer's disease	9.39e-05	0.000287	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PLCB1—Alzheimer's disease	9.3e-05	0.000284	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—A2M—Alzheimer's disease	9.18e-05	0.000281	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPARG—Alzheimer's disease	9.18e-05	0.00028	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NCSTN—Alzheimer's disease	9.15e-05	0.000279	CbGpPWpGaD
Methyldopa—COMT—Metabolism—INS—Alzheimer's disease	9e-05	0.000275	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LRP1—Alzheimer's disease	8.92e-05	0.000273	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NOS3—Alzheimer's disease	8.89e-05	0.000272	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GAL—Alzheimer's disease	8.71e-05	0.000266	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GFAP—Alzheimer's disease	8.71e-05	0.000266	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF1—Alzheimer's disease	8.53e-05	0.000261	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS2—Alzheimer's disease	8.13e-05	0.000248	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ACHE—Alzheimer's disease	7.99e-05	0.000244	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—INPP5D—Alzheimer's disease	7.9e-05	0.000241	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NOS3—Alzheimer's disease	7.89e-05	0.000241	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS3—Alzheimer's disease	7.74e-05	0.000236	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—A2M—Alzheimer's disease	7.68e-05	0.000235	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.57e-05	0.000231	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS1—Alzheimer's disease	7.49e-05	0.000229	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ENO1—Alzheimer's disease	7.49e-05	0.000229	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PSEN2—Alzheimer's disease	7.44e-05	0.000227	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP2D6—Alzheimer's disease	7.34e-05	0.000224	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS2—Alzheimer's disease	7.22e-05	0.000221	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	7.17e-05	0.000219	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.02e-05	0.000214	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—BCHE—Alzheimer's disease	6.96e-05	0.000213	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	6.9e-05	0.000211	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	6.87e-05	0.00021	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPY—Alzheimer's disease	6.84e-05	0.000209	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IAPP—Alzheimer's disease	6.8e-05	0.000208	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CRH—Alzheimer's disease	6.6e-05	0.000202	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLCB1—Alzheimer's disease	6.57e-05	0.000201	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCR5—Alzheimer's disease	6.51e-05	0.000199	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	6.37e-05	0.000195	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	6.37e-05	0.000194	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	6.26e-05	0.000191	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	6.23e-05	0.00019	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	6.15e-05	0.000188	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	6.14e-05	0.000188	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	5.97e-05	0.000182	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	5.97e-05	0.000182	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	5.97e-05	0.000182	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	5.95e-05	0.000182	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	5.92e-05	0.000181	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	5.82e-05	0.000178	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	5.59e-05	0.000171	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	5.57e-05	0.00017	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	5.49e-05	0.000168	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	5.49e-05	0.000168	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	5.46e-05	0.000167	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	5.12e-05	0.000157	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	5.12e-05	0.000156	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	5.09e-05	0.000156	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	5e-05	0.000153	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LPL—Alzheimer's disease	4.99e-05	0.000153	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	4.98e-05	0.000152	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	4.73e-05	0.000145	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	4.51e-05	0.000138	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	4.5e-05	0.000137	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	4.36e-05	0.000133	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TP53—Alzheimer's disease	4.21e-05	0.000129	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CALM1—Alzheimer's disease	4.2e-05	0.000128	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOE—Alzheimer's disease	4.19e-05	0.000128	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	4.18e-05	0.000128	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CAV1—Alzheimer's disease	4.15e-05	0.000127	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	4.14e-05	0.000126	CbGpPWpGaD
Methyldopa—DDC—Metabolism—AKT1—Alzheimer's disease	4.09e-05	0.000125	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	4.06e-05	0.000124	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	3.96e-05	0.000121	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	3.85e-05	0.000118	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	3.77e-05	0.000115	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPARG—Alzheimer's disease	3.65e-05	0.000111	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AKT1—Alzheimer's disease	3.63e-05	0.000111	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—INS—Alzheimer's disease	3.58e-05	0.000109	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	3.56e-05	0.000109	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	3.51e-05	0.000107	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	3.5e-05	0.000107	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	3.5e-05	0.000107	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.47e-05	0.000106	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	3.34e-05	0.000102	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	3.3e-05	0.000101	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.23e-05	9.87e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NOS3—Alzheimer's disease	3.14e-05	9.58e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.03e-05	9.26e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	3.01e-05	9.19e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.99e-05	9.14e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	2.94e-05	8.99e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.89e-05	8.84e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.87e-05	8.76e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.62e-05	8.01e-05	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.25e-05	6.87e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.23e-05	6.8e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	2.21e-05	6.76e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.05e-05	6.25e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.04e-05	6.23e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.89e-05	5.77e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.73e-05	5.3e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.44e-05	4.4e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.43e-05	4.36e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.31e-05	3.99e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.21e-05	3.68e-05	CbGpPWpGaD
